Journal for ImmunoTherapy of Cancer (Nov 2020)
123 Natural killer cells engineered with an inducible, responsive genetic construct targeting TIGIT and CD73 to relieve immunosuppression within the GBM microenvironment
Abstract
No abstracts available.